Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Senate Finance Considering Clinical Trials Registry Legislation

This article was originally published in The Pink Sheet Daily

Executive Summary

Senate Finance Committee Chair Chuck Grassley (R-Iowa) is planning a bill to establish a clinical trial registry

You may also be interested in...



Sen. Grassley Suggests 9/11-Like Commission On Drug Safety

Senate Finance Committee Chair Grassley says an independent commission of experts could provide recommendations to the executive branch and Congress. "It seems the time has come for a comprehensive review of drug safety," he says.

Sen. Grassley Suggests 9/11-Like Commission On Drug Safety

Senate Finance Committee Chair Grassley says an independent commission of experts could provide recommendations to the executive branch and Congress. "It seems the time has come for a comprehensive review of drug safety," he says.

Leavitt To Face Questioning In Senate Finance, Health Committees

Bush Administration nominee Michael Leavitt will face questioning from two Senate committees in his bid to succeed HHS Secretary Tommy Thompson

Related Content

Topics

UsernamePublicRestriction

Register

PS078529

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel